A recent study from Columbia University found that chlorthalidone, the guideline-recommended diuretic for lowering blood pressure, causes more serious side effects than hydrochlorothiazide, a similarly effective diuretic.
The findings contrast with current treatment guidelines recommending chlorthalidone over hydrochlorothiazide.
In the study, the team looked at 17 years of data on more than 730,000 people treated for high blood pressure.
They found that chlorthalidone and hydrochlorothiazide were similarly effective in preventing a heart attack, hospitalization for heart failure, and stroke.
However, patients taking chlorthalidone had nearly three times the risk of developing dangerously low levels of potassium and a greater risk of other electrolyte imbalances and kidney problems compared with those taking hydrochlorothiazide.
The side effects can lead to abnormal heart rhythms; hyponatremia (low sodium), which can cause confusion, kidney failure, and type 2 diabetes.
The team found that 6.3% of patients treated with chlorthalidone experienced hypokalemia (low blood potassium), compared with 1.9% of patients who were treated with hydrochlorothiazide.
Hypokalemia rates remained higher for patients taking chlorthalidone even when given at a lower dose than hydrochlorothiazide.
The researchers say that doctors prescribing chlorthalidone should monitor for certain side effects in their patients.
The study is not the first to find side effects linked to chlorthalidone. A previous observational study found that the drug was linked to more electrolyte imbalances than hydrochlorothiazide.
If you care about high blood pressure, please read studies about this daily food may help reduce your risk of diabetes, high blood pressure and findings of this common nutrient may help prevent high blood pressure.
For more information about high blood pressure prevention and treatment, please see recent papers about a new major cause of high blood pressure and results showing the key to treating high blood pressure.
The study was published in JAMA Internal Medicine and conducted by George Hripcsak, et al.
Copyright © 2022 Knowridge Science Report. All rights reserved.